Skip to content
Screener

BioCryst Pharmaceuticals BCRX Unrealized Gains on Investments

Unrealized Gains on Investments at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$516K-79.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$0—
Amgen logo
AmgenAMGN
$0—
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
——
Precigen logo
PrecigenPGEN
——
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
——

Other financials

Income statement

See full
Revenue$218.3M+33.6%
Gross profit$214.4M+33.5%
Operating income$98.5M+231%
Net income$78.4M+1,442%
EPS (diluted)$0.30+1,400%

Balance sheet

See full
Cash & equivalents$156.4M+73.9%
Total debt$410.9M+59.9%
Total equity-$454.3M-7.8%
Total assets$557.9M+22.0%

Cash flow

See full
Operating cash flow$104.3M+153%
CapEx$209.0K+16.8%
Free cash flow$104.1M+153%

Valuation

See full
Market cap$2.51B+46.1%
Enterprise value$2.77B+46.6%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-33.3%-43.0pp
Net margin-40.9%-50.2pp
FCF margin39.7%—

Returns & leverage

See full
Return on equity-882.8%—
Debt / equity0.1×—
Current ratio2.3×+0.1×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053300
Line itemAmortized CostAccrued InterestGross Unrealized GainsGross Unrealized LossesEstimated Fair Value
Obligations of U.S. Government and its agencies$197,381$447—$(227)$197,601
Total investments$197,381$447—$(227)$197,601

Item 1. Financial Statements (Unaudited):

FAQ

What is BioCryst Pharmaceuticals's unrealized gains on investments?
BioCryst Pharmaceuticals (BCRX) reported unrealized gains on investments of $0 in Q2 2026.
How has BioCryst Pharmaceuticals's unrealized gains on investments changed year-over-year?
BioCryst Pharmaceuticals's unrealized gains on investments decreased by 100.0% year-over-year, from $114K to $0.
What does unrealized gains on investments mean?
The total unrealized gains on investments, typically related to available-for-sale securities.

Ask your AI about BioCryst Pharmaceuticals's unrealized gains on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude